Your Login Session is about to expire due to inactivity.
Did you know that more women are diagnosed with breast cancer than any other type of cancer besides skin cancer? According to the American Cancer Society, an estimated 281,550 women in the United States will be diagnosed with invasive breast cancer, 49,290 women will be diagnosed with non-invasive (in situ) breast cancer, and 43,600 women will die from the disease this year alone.1
Furthermore, breast cancer is the second most common cause of death from cancer in women in the United States after lung cancer. Thanks to early detection and improvements in treatment, the number of women who died of breast cancer decreased by 41% from 1989 to 2018. This decline resulted in more than 403,000 breast cancer deaths being prevented during that period.2
Unfortunately, like many things, COVID-19 negatively impacted numerous areas of health care, and breast cancer intervention was no exception. As a result, there is an even greater need for awareness and early detection regarding this critical aspect of women’s health.
Along with early detection, you can support your patients in helping to lower their breast cancer risk through these efforts:
Encouraging regular check-ups, mammograms, and screenings.
Assisting them in maintaining a healthy weight and encouraging them to exercise regularly.
Encouraging them to avoid alcohol or limiting the amount of alcohol they drink.
Discussing the potential risks associated with hormone replacement therapy and birth control.
Encouraging them to breastfeed their infant and newborn children, if possible.
This October, join Evexia Diagnostics and others worldwide by showing support for people affected by breast cancer. Evexia looks to provide help and inspire hope for those affected by breast cancer through early detection, education, and support services.
This panel assesses hormone balance, overall health, and healthy aging by measuring specific hormone levels and other markers that can be indicators of hormone imbalance. The particular analytes addressed in this panel are the estrogens, testosterone, progesterone, 17-hydroxypregnenolone, pregnenolone, androstenedione, prolactin, insulin-like growth factor 1, thyroid hormones, sex hormone-binding globulin, the adrenal gland biomarkers DHEA and cortisol, FSH and LH, markers of glucose regulation (insulin, HbA1c). Also included are fundamental blood test markers such as the CBC with differential, comprehensive metabolic panel, an iron panel, a lipid panel, magnesium, and vitamin D.
This panel assesses hormone balance, overall health, and healthy aging by measuring specific hormone levels and other markers that can be indicators of hormone imbalance. The particular analytes addressed in this panel are the estrogens, testosterone, progesterone, thyroid hormones, sex hormone-binding globulin, the adrenal gland biomarkers DHEA and cortisol, FSH and LH, markers of glucose regulation (insulin, HbA1c). Also included are fundamental blood test markers such as the CBC with differential, comprehensive metabolic panel, an iron panel, a lipid panel, magnesium, and vitamin D.
The Evexia Diagnostics Breast Cancer Profile includes a complete blood count, several tumor markers (CA 15-3, CA 27.29, and carcinoembryonic antigen -CEA), estradiol, as well as markers of inflammation and analytes such as lipid-associated sialic acid, matrix metalloproteinase-9 (MMP-9), and vascular endothelial growth factor (VEGF).
WHY USE DUTCH? The Easiest Patient Collection: Patients collect just four or five dried urine samples over a 24-hour period. Dried samples are stable for several weeks making them convenient to ship worldwide. Analytical and Clinical Validation: Precision Analytical’s testing methods go through a rigorous validation process to verify accuracy, recovery, and linearity. We pride ourselves in relentlessly pursuing the most accurate and precise techniques available for testing.
For some women, testing reproductive hormones (progesterone, estrogen, etc.) on a single day is sufficient. In other scenarios, the clinical picture cannot be properly captured without “mapping” out the hormonal pattern throughout their menstrual cycle.
The expected pattern of hormones shows relatively low estrogen levels early in the cycle, a surge around ovulation and modest levels in the latter third of the cycle (the luteal phase). Progesterone levels, on the other hand, stay relatively low until after ovulation. After ovulation, levels ideally increase (>10-fold) and then drop back down at the end of the cycle. A disruption in this cycle can lead to infertility or hormonal imbalance.
WHY USE DUTCH? The Easiest Patient Collection: Patients collect just four or five dried urine samples over a 24-hour period. Dried samples are stable for several weeks making them convenient to ship worldwide. Analytical and Clinical Validation: Precision Analytical’s testing methods go through a rigorous validation process to verify accuracy, recovery, and linearity. We pride ourselves in relentlessly pursuing the most accurate and precise techniques available for testing.
For some women, testing reproductive hormones (progesterone, estrogen, etc.) on a single day is sufficient. In other scenarios, the clinical picture cannot be properly captured without “mapping” out the hormonal pattern throughout their menstrual cycle.
The expected pattern of hormones shows relatively low estrogen levels early in the cycle, a surge around ovulation and modest levels in the latter third of the cycle (the luteal phase). Progesterone levels, on the other hand, stay relatively low until after ovulation. After ovulation, levels ideally increase (>10-fold) and then drop back down at the end of the cycle. A disruption in this cycle can lead to infertility or hormonal imbalance.
Genetics make up the baseline "code" by which your body functions. The impact of every single choice you make throughout your life is influenced by your personal genetic makeup. We test over 130 genes that can affect your metabolism, inflammation, detoxification, fitness, weight, hormones, cognition, and response to your diet and supplements.
By understanding how your unique genetics impact these key processes, you can make smarter, more personalized decisions about your health in order to reach your health goals, whatever they may be.
The Comprehensive Hormone Panel is the starting point for initial assessment of hormonal status and endocrine function and includes estradiol (E2), progesterone, testosterone, DHEA and four cortisols. This panel is useful with male and female patients because it looks at the full diurnal cortisol pattern; it is especially important in patients who are experiencing the following symptoms in addition to the symptoms listed for the Basic Hormone Panel:
The Comprehensive Plus Panel expands on the Comprehensive Hormone Panel and includes estrone (E1) and estriol (E3) plus the Estrogen Quotient. The Estrogen Quotient (EQ) is a simple ratio of the cancer protective E3 to the proliferative estrogens E1 and E2. The EQ provides an assessment of breast cancer risk, with a lower number (<1.0) indicating increased risk, and a higher number (>1.0) signifying a lower risk. For maximum protection, an optimal EQ is >1.5.
Because the research on the Estrogen Quotient and the protective properties of estriol has not been done with men, this panel is currently recommended for women only. This panel should be considered for patients who have:
Increased risk of developing breast cancer
History of breast cancer or other hormonally sensitive cancers
1American Cancer Society. How Common Is Breast Cancer? Jan. 2021. https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html. 2Cancer.Net Breast Cancer: Statistics https://www.cancer.net/cancer-types/breast-cancer/statistics
National Breast Cancer Coalition https://www.stopbreastcancer.org/information-center/facts-figures/
You are attempting to learn about a feature that is not available to an EvexiaLite account status. To gain access to this feature please click the button below to upgrade to an EvexiaComplete account where you will have access to:
Unbeatable pricing on Diagnostic Testing
Access to over 6000 Conventional and Specialty tests
EvexiaDirect - Patients pay directly for orders you assign.
Client bill - You pay Evexia and then set your own patient pricing
Access to our Custom Panel Creator
EMR/ EHR Integration
Access to Thousands of Patient Service Centers
Extended client hours 8 am - 8 pm, 5 days a week. Email support for urgent matters on weekend and holidays.
Free Functional Health Reports
Free Ask the Doctor Interpretive Consultations
Free Customized Marketing Support Materials
For $50 a year get the complete experience.
Congratulations!
Your EvexiaLite account has been upgraded to EvexiaComplete.
You will now be logged out and required to log back in to start taking advantage of EvexiaComplete.